Fondazione del Piemonte per lOncologia (IRCCS)

Candiolo, Piedmont 10060

0 studies enrolling now · 4 studies all time

What they study most

Diffuse Large B Cell Lymphoma, HER2 Amplification, HER2 Gene Mutation, HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, Relapsed and/or Refractory Multiple Myeloma, TGCT

Studies at this site

• Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) — Running, not enrolling
• Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients — Running, not enrolling
• ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer — Running, not enrolling
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed